Hormone replacement, race, and pyschological health in women: A report from the NHLBI-sponsored WISE Study

Journal of Women's Health

Volumn 13, Issue 3, 2004, Pages 325-332

  Olson, Marian B ^a   Merz, Noel Bairey ^b   Shaw, Leslee J ^c   Mankad, Sunil ^d   Reis, Steven E ^e   Pohost, Gerald M ^f   Smith, Karen M ^g   McGorray, Susan P ^g   Cornell, Carol E ^h   Kelsey, Sheryl F ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c Atlanta Cardiovasc Res Institute   (United States)

^d ALLEGHENY GENERAL HOSPITAL   (United States)

^e UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^g UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^h University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; PROGESTERONE;

ADULT; AGGRESSION; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; BECK DEPRESSION INVENTORY; CAUCASIAN; CLINICAL STUDY; CONTROLLED STUDY; DEPRESSION; DISEASE DURATION; FEMALE; HEART MUSCLE ISCHEMIA; HORMONE SUBSTITUTION; HOSTILITY; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; MENTAL HEALTH; NEGRO; PREDICTION; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; RACE DIFFERENCE; SCORING SYSTEM; SOCIAL PSYCHOLOGY; SYMPTOMATOLOGY;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGGRESSION; ATTITUDE TO HEALTH; DEPRESSION; ESTROGEN REPLACEMENT THERAPY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HOSTILITY; HUMANS; MIDDLE AGED; MYOCARDIAL ISCHEMIA; POSTMENOPAUSE; QUALITY OF LIFE; REGRESSION ANALYSIS; RISK FACTORS; SOCIOECONOMIC FACTORS; TIME FACTORS; UNITED STATES; WOMEN'S HEALTH;

EID: 2442718827     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/154099904323016482     Document Type: Article

References (25)

1. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321.
2. Hully S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998;280:605.
3. Barrett-Conner E, Grady D. Hormone replacement therapy, heart disease, and other considerations. Annu Rev Public Health 1998;19:55.
4. Grodstein F, Manson JE, Colditz GA, Willet WC, Speizer FE, Stampfer Mj. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med 2000;133:933.
5. Tosteson AN, Gabriel SE, Kneeland TS, et al. Has the impact of hormone replacement therapy on health-related quality of life been undervalued? J Wom Health Gender-Based Med 2000;9:119.
6. Zethraeus N, Johannesson M, Henriksson P, Strand RT. The impact of hormone replacement therapy on quality of life and willingness to pay. Br J Obstet Gynaecol 1997;104:1191.
7. Collins A, Landgren BM. Psychosocial factors associated with the use of hormonal replacement therapy in the longitudinal follow-up of Swedish women. Maturitas 1997;28:1.
8. Steffan AM, Thompson LW, Gallagher-Thompson D, Koin D. Physical and psychosocial correlates of hormone replacement therapy with chronically stressed postmenopausal women. J Aging Health 1999;11:3.
9. Wiklund I, Karlberg J, Mattsson LA. Quality of life of postmenopausal women on a regimen of transdermal estradiol therapy: A double-blind placebo-controlled study. Am J Obstet Gynecol 1993;168:824.
10. Adamson DL, Webb CM, Collins P. Esterified estrogens combined with methyltestosterone improve emotional well-being in postmenopausal women with chest pain and normal coronary angiograms. Menopause 2001;8:233.
11. Hays J, Ockene JK, Brunner RL, et al. Effects of estrogen plus progestin on health-related quality of life. N Engl J Med 2003;348:1839.
12. Hlatky MA, Boothroyd D, Viltinghoff E, Sharp P, Whooley MA, for the HERS Research Group. Quality of life and depressive symptoms in postmenopausal women after receiving hormone therapy. Results from the Heart and Estrogen/Progestin Replacement Study (HERS) Trial. JAMA 2002;287:591.
13. Nicholson WK, Brown AF, Gathe J, Grumbach K, Washington AE, Perez-Stable EJ. Hormone replacement therapy for African-American women: Missed opportunities for effective intervention. Menopause 1999;6:147.
14. Bairey Merz CN, Kelsey SF, Pepine CJ, et al. The Women's Ischemia Syndrome Evaluation (WISE) study: Protocol design, methodology and feasibility report. J Am Coll Cardiol 1999;33:1453.
15. Spilker B, ed. Quality of life and pharmacoeconomics in clinical trials, 2nd ed. Lippincott-Raven, New York, 1996.
16. Beck AT, Steer RA, Garbin MG. Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation. Clin Psychol Rev 1988;8:77.
17. Helmer DC, Ragland DR, Syme SL. Hostility and coronary artery disease. Am J Epidemiol 1991;133:112.
18. Barefoot JC, Dodge KA, Peterson BL, Dahlstrom WG, Williams RB. The Cook-Medley hostility scale: Item content and ability to predict survival. Psychosom Med 1989;51:46.
19. Grisso JA, Freeman EW, Maurin E, Garcia-Espana B, Berlin JA. Racial differences in menopause information and the experience of hot flashes. J Gen Intern Med 1999;14:98.
20. Miller WJ, Montgomery A, Chandler P. Sociodemographic characteristics, biological factors, and symptom reporting in midlife women. Menopause 1998;5:43.
21. Skarsgard C, Berg GE, Ekblad S, Wiklund I, Hammar ML. Effects of estrogen therapy on well-being in postmenopausal women without vasomotor complaints. Maturitas 2000;36:123.
22. Limouzin-Lamothe MA, Mairon N, Joyce CR, Le Gal M. Quality of life after the menopause: Influence of hormonal replacement therapy. Am J Obstet Gynecol 1994;170:618.
23. Rosenberg L, Palmer JR, Rao RS, Adams-Campbell LL. Correlates of postmenopausal female hormone use among black women in the United States. Obstet Gynecol 1998;91:454.
24. McNagny SE, Jacobson TA. Use of postmenopausal hormone replacement by African American women. The importance of physician discussion. Arch Intern Med 1997;157:1337.
25. Olson MB, Bairey Merz CN, Kelsey SF, et al. Hostility scores are associated with increased risk of events in women undergoing coronary angiography: Results from the NHLBI-sponsored WISE study. Circulation 2003;108 (Suppl):716.